782
Views
29
CrossRef citations to date
0
Altmetric
Review Article

Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature

, , &
Pages 129-137 | Received 18 Jun 2014, Accepted 15 Jul 2014, Published online: 12 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Søren Møller, Karen V. Danielsen, Puria Nabilou, Nina Kimer & Flemming Bendtsen. (2023) Beta-adrenergic blockade in cirrhosis – harmful or helpful?. Expert Review of Gastroenterology & Hepatology 17:6, pages 519-529.
Read now
Søren Møller & Flemming Bendtsen. (2015) Complications of cirrhosis. A 50 years flashback. Scandinavian Journal of Gastroenterology 50:6, pages 763-780.
Read now

Articles from other publishers (27)

Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore & Juan C. Camacho. (2022) Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 24:11, pages 1461-1475.
Crossref
Anand V. Kulkarni, Atoosa Rabiee & Arpan Mohanty. (2022) Management of Portal Hypertension. Journal of Clinical and Experimental Hepatology 12:4, pages 1184-1199.
Crossref
Luis Téllez & Agustín Albillos. (2022) Non‐selective beta‐blockers in patients with ascites: The complex interplay among the liver, kidney and heart. Liver International 42:4, pages 749-761.
Crossref
T. Bentsa. (2020) Liver Cirrhosis: Modern Approach to the Problem. Lviv clinical bulletin 3:31, pages 53-61.
Crossref
Amanda C. Bultas, Besu Teshome, Sara K. Richter, Stephen Schafers, Emily Cooke & William B. Call. (2019) Use of Nonselective β-Blockers in Patients With End-Stage Liver Disease and Select Complications. Annals of Pharmacotherapy 54:6, pages 583-593.
Crossref
Jenna L. Snoga, Kathleen A. Lusk, Russell T. Attridge & Rebecca L. Attridge. (2019) Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis. Annals of Pharmacotherapy 54:4, pages 322-330.
Crossref
Robert J. Wong, Ann Robinson, Dina Ginzberg, Chantal Gomes, Benny Liu & Taft Bhuket. (2019) Assessing the safety of beta‐blocker therapy in cirrhosis patients with ascites: A meta‐analysis. Liver International 39:6, pages 1080-1088.
Crossref
José Roberto Macías-Pérez, Bruno Jesús Vázquez-López, Martin Humberto Muñoz-Ortega, Liseth Rubí Aldaba-Muruato, Sandra Luz Martínez-Hernández, Esperanza Sánchez-Alemán & Javier Ventura-Juárez. (2019) Curcumin and α / β -Adrenergic Antagonists Cotreatment Reverse Liver Cirrhosis in Hamsters: Participation of Nrf-2 and NF- κ B . Journal of Immunology Research 2019, pages 1-12.
Crossref
Jin Hwa Park, Dae Won Jun, Jun Choi, Dong Hee Koh, Jai Hoon Yoon, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Byung Chul Yoon & Ho Soon Choi. (2019) Low-Dose Propranolol as Secondary Prophylaxis for Varix Bleeding Decreases Mortality and Rebleeding Rate in Patients with Tense Ascites. Journal of Clinical Medicine 8:5, pages 573.
Crossref
François Durand, Claire Francoz, Sumeet K. Asrani, Saro Khemichian, Thomas A. Pham, Randall S. Sung, Yuri S. Genyk & Mitra K. Nadim. (2018) Acute Kidney Injury After Liver Transplantation. Transplantation 102:10, pages 1636-1649.
Crossref
Antonio Facciorusso, Sunil Roy, Sarantis Livadas, Adwalia Fevrier-Paul, Clara Wekesa, Ismail Dogu Kilic, Amit Kumar Chaurasia, Mina Sadeq & Nicola Muscatiello. (2018) Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites. Digestive Diseases and Sciences 63:7, pages 1737-1746.
Crossref
Carlos Moctezuma‐Velazquez, Sylvia Kalainy & Juan G. Abraldes. (2017) Beta‐blockers in patients with advanced liver disease: Has the dust settled?. Liver Transplantation 23:8, pages 1058-1069.
Crossref
Parastoo Jangouk & Guadalupe Garcia-Tsao. (2017) Primary and secondary prophylaxis of esophageal variceal bleeding. Techniques in Gastrointestinal Endoscopy 19:2, pages 84-89.
Crossref
Thomas Reiberger & Mattias Mandorfer. (2017) Beta adrenergic blockade and decompensated cirrhosis. Journal of Hepatology 66:4, pages 849-859.
Crossref
Sara Blasco-Algora, José Masegosa-Ataz, Sonia Alonso, Maria-Luisa Gutiérrez & Conrado Fernández-Rodriguez. (2016) Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterology 3:1, pages e000104.
Crossref
Basile Njei, Thomas R McCarty & Guadalupe Garcia-Tsao. (2016) Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters. Gut 65:8, pages 1393-1394.
Crossref
Sakkarin Chirapongsathorn, Nelson Valentin, Fares Alahdab, Chayakrit Krittanawong, Patricia J. Erwin, Mohammad H. Murad & Patrick S. Kamath. (2016) Nonselective β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 14:8, pages 1096-1104.e9.
Crossref
Gennaro D'Amico, Giuseppe Malizia & Jaime Bosch. (2016) Beta‐blockers in 2016: Still the safest and most useful drugs for portal hypertension?. Hepatology 63:6, pages 1771-1773.
Crossref
L. Téllez, M. Aicart-Ramos, M.A. Rodríguez-Gandía, J. Martínez & A. Albillos. (2016) Ascitis: diagnóstico diferencial y tratamiento. Medicine - Programa de Formación Médica Continuada Acreditado 12:12, pages 673-682.
Crossref
Agustín Albillos, Javier Martínez & Luis Téllez. (2015) Continued controversy over the safety of beta‐blockers in decompensated cirrhosis. Hepatology 63:5, pages 1726-1729.
Crossref
Rajeshwar P. Mookerjee, Marco Pavesi, Karen Louise Thomsen, Gautam Mehta, Jane Macnaughtan, Flemming Bendtsen, Minneke Coenraad, Jan Sperl, Pere Gines, Richard Moreau, Vicente Arroyo & Rajiv Jalan. (2016) Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. Journal of Hepatology 64:3, pages 574-582.
Crossref
Alberto Ferrarese, Alberto Zanetto, Giacomo Germani, Patrizia Burra & Marco Senzolo. (2016) Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension. World Journal of Hepatology 8:24, pages 1012.
Crossref
Thomas Reiberger, Richard Moreau, Cristina Ripoll, Agustin Albillos, Salvador Augustin, Francesco Salerno, Juan G. Abraldes & Guadalupe Garcia-Tsao. 2016. Portal Hypertension VI. Portal Hypertension VI 317 332 .
Manuela Merli & Roberto J. Groszmann. 2016. Portal Hypertension VI. Portal Hypertension VI 215 224 .
Carlo Merkel & Aleksander Krag. 2016. Portal Hypertension VI. Portal Hypertension VI 187 194 .
Guadalupe Garcia-Tsao & Jaime Bosch. (2015) Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clinical Gastroenterology and Hepatology 13:12, pages 2109-2117.
Crossref
Juan G. Abraldes & Puneeta Tandon. (2015) The Use of Beta-Blockers in Advanced Cirrhosis—Where Do We Stand?. Current Hepatology Reports 14:1, pages 46-52.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.